ikenaoncology.com (IMA) - Total pendapatan perusahaan
A stable patent moat in the field of targeted immuno-oncology ensures the resilience of ImageneBio Inc. The operating model relies on outsourcing clinical trials to optimize R&D costs. The company's sales revenue on the chart confirms demand dynamics, where the indicator value reaches 0.00. Growth potential is driven by successes in precision cancer therapy and new partnerships.
Rincian metrik komprehensif lan analitis ImageneBio (IMA)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal ImageneBio Inc|IMA - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Ikena Oncology, Inc.|IMA - Gunggung utang perusahaan|Utang-utang marang nilai buku ImageneBio Inc|IMA - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Ikena Oncology|Likuiditas darurat ikenaoncology.com
- rincian bathi lan kelipatan pasar:
IMA - Bathi resik|Bathi sing dikarepake ImageneBio Inc|IMA - Pangali P/E|Kapitalisasi marang proyeksi bathi Ikena Oncology, Inc.|IMA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ImageneBio Inc|IMA - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Ikena Oncology|IMA - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan ikenaoncology.com|IMA - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep ImageneBio Inc
- indikator volume dodolan lan pendapatan:
Ringkesan analisis perusahaan:IMA (ikenaoncology.com)
Investors are assessing the potential of ImageneBio Inc (IMA) through the company's ability to monetize its scientific developments. This metric represents the aggregate of all daily commercial inflows, reflecting the actual cash flow from product sales. Analyzing the company's operational sales allows for the timely detection of liquidity declines during price stagnation. Stable revenue growth confirms the effectiveness of investments in elite biologists and costly targeted therapy programs.
Analisis perusahaan pesaing
Volume dodolan perusahaan ARGX (argenx BVBA)|Pendapatan lan volume dodolan BNTX|ABVX - Total pendapatan perusahaan|Pendapatan lan volume dodolan ADMA (ADMA Biologics, Inc.)|Pendapatan reged perusahaan Protagonist Therapeutics, Inc. (PTGX)|IMVT - Pendapatan perusahaan|Kiniksa Corp (KNSA) - Dodolan perusahaan|GRFS: Pendapatan lan volume dodolan|adaptivebiotech.com (ADPT) - Pendapatan lan volume dodolan|CLDX (Celldex Therapeutics, Inc.) - Pendapatan lan volume dodolan|AUPH - Total volume dodolan perusahaan|Pendapatan lan volume dodolan BCRX|VERA - Total pendapatan perusahaan|Pendapatan perusahaan Dianthus Therapeutics DNTH|PHVS: Volume dodolan perusahaan|AbCellera - Pendapatan lan volume dodolan|Total pendapatan perusahaan Tourmaline Bio Inc|PGEN: Pendapatan lan volume dodolan|PHAR (Pharming Corp) - Pendapatan perusahaan|NKTR (Nektar Therapeutics) - Pendapatan lan volume dodolan|upstreambio.com (UPB) - Pendapatan reged perusahaan|Pendapatan perusahaan Zenas Biopharma (ZBIO)|IMNM - Total pendapatan perusahaan|Gossamer Corp - Dodolan perusahaan|Pendapatan dodolan perusahaan KALV|Septerna Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan pieris.com PVLA|Savara (SVRA) - Pendapatan perusahaan|Volume dodolan perusahaan RIGL|ANAB (AnaptysBio Corp) - Pendapatan lan volume dodolan|Dodolan perusahaan Astria Corp (ATXS)|Pendapatan lan volume dodolan ENGN|Pendapatan reged perusahaan rapt.com|Pendapatan perusahaan Aerovate Therapeutics JBIO|ACRS - Dodolan perusahaan|Kyverna - Pendapatan lan volume dodolan|TLSA - Pendapatan lan volume dodolan|Cabaletta Bio, Inc. (CABA) - Pendapatan perusahaan|Pendapatan tahunan perusahaan VTYX (ventyxbio.com)|THTX (Theratechnologies) - Pendapatan lan volume dodolan|AVTX: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan ELDN|Pendapatan lan volume dodolan Agenus, Inc (AGEN)|Pendapatan perusahaan Climb Bio Inc CLYM|Pendapatan dodolan perusahaan ZURA|ATYR - Pendapatan perusahaan|Adagene (ADAG) - Dodolan perusahaan|STTK: Pendapatan lan volume dodolan|Equillium (EQ) - Pendapatan lan volume dodolan|Dodolan perusahaan CNTB|IMUX: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan ATRA|Pendapatan reged perusahaan inflarx.de|Pendapatan perusahaan X4 Pharma XFOR|ACET - Dodolan perusahaan|CELU - Pendapatan perusahaan|inmunebio.com (INMB) - Dodolan perusahaan|BRNS (Barinthus Biotherapeutics plc) - Dodolan perusahaan|Kezar Life Sciences Inc. (KZR) - Pendapatan lan volume dodolan|Pendapatan perusahaan SAB Biotherapeutics, Inc|Volume dodolan perusahaan AKTX (Akari Therapeutics, Plc)|Pendapatan lan volume dodolan ENLV|QTTB - Total pendapatan perusahaan|Pendapatan lan volume dodolan GOVX (GeoVax)|Pendapatan reged perusahaan Edesa Biotech Inc (EDSA)|IBIO - Pendapatan perusahaan|Carisma Therapeutics (CARM) - Dodolan perusahaan|XTLB: Pendapatan lan volume dodolan|Bolt Biotherapeutics, Inc. (BOLT) - Pendapatan lan volume dodolan|HCWB (HCW Biologics, Inc.) - Pendapatan lan volume dodolan|APVO - Total volume dodolan perusahaan|Pendapatan lan volume dodolan AIM|ADTX - Total pendapatan perusahaan|Pendapatan perusahaan GRI Bio, Inc. GRI|XRTX: Volume dodolan perusahaan|Vyome Holdings - Pendapatan lan volume dodolan|Total pendapatan perusahaan Revelation Biosciences Inc|INDP: Pendapatan lan volume dodolan|SCNI (BiondVax Pharmaceuticals) - Pendapatan perusahaan|CALI (CalciMedica Inc) - Pendapatan lan volume dodolan|Affimed Therapeutics (AFMD) - Pendapatan reged perusahaan|Pendapatan perusahaan Allakos Inc. (ALLK)|HOOK - Total pendapatan perusahaan|IGM Biosciences - Dodolan perusahaan|Pendapatan dodolan perusahaan ITOS|Ocean Biomedical, Inc. - Pendapatan lan volume dodolan|Pendapatan reged perusahaan tcbiopharm.com TCBP|Third Harmonic Bio, Inc. (THRD) - Pendapatan perusahaan
